e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Activated CD8 T-lymphocytes in obstructive sleep apnoea
Dyugovskaya L., Lavie P., Hirsh M., Lavie L.
Source:
Eur Respir J 2005; 25: 820-828
Journal Issue:
May
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dyugovskaya L., Lavie P., Hirsh M., Lavie L.. Activated CD8 T-lymphocytes in obstructive sleep apnoea. Eur Respir J 2005; 25: 820-828
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001
Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 1077-1084
Year: 2009
Monocytes inhibit NK activity
via
TGF-ß in patients with obstructive sleep apnoea
Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016
Year: 2017
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Expression of cysteinyl leukotriene receptors in tonsillar T and B lymphocytes of children with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
LATE-BREAKING ABSTRACT: The pattern of lymphocyte subpopulations including Fas positive cells in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity
Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Year: 2013
Circulating dendritic cell subsets are reduced in obstructive sleep apnoea patients: study correlation with inflammation markers
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Impact of alfa delta sleep, but not obstructive sleep apneas on potential cardiotoxic CD4 lymphocytes
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017
Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003
Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept